What is the appropriate treatment for alcoholic gastritis?

Treatment of Alcoholic Gastritis

The primary treatment for alcoholic gastritis is immediate and complete alcohol abstinence combined with proton pump inhibitor therapy, nutritional support with 35-40 kcal/kg/day and protein 1.2-1.5 g/kg/day, and comprehensive vitamin supplementation, particularly thiamine and B-complex vitamins. 1

Immediate Management

Alcohol Cessation

• Absolute alcohol abstinence is the cornerstone of treatment and must be enforced, as continued alcohol consumption perpetuates mucosal damage and inflammation. 1
• Brief alcohol intervention during hospitalization reduces future alcohol consumption by approximately 41 g/week and should be initiated immediately. 1
• Extended alcohol counseling must be arranged after discharge to maintain long-term abstinence. 1

Acid Suppression Therapy

• Initiate proton pump inhibitors (PPIs) immediately to reduce gastric acid secretion and promote mucosal healing. 1
• PPIs are more effective than H2-receptor antagonists for symptomatic relief in alcohol-induced gastritis. 1
• Continue PPI therapy until mucosal healing is confirmed and symptoms completely resolve. 1
• Note that H2-receptor antagonists do not prevent ethanol-induced mucosal damage, as alcohol remains ulcerogenic despite antisecretory therapy. 2

Nutritional Therapy

Caloric and Protein Requirements

• Provide 35-40 kcal/kg/day with protein intake of 1.2-1.5 g/kg/day. 1
• For severely ill patients, increase protein intake to 1.5 g/kg/day. 1
• If oral intake is inadequate, initiate enteral feeding via nasogastric tube—parenteral nutrition alone is insufficient. 1

Vitamin and Mineral Supplementation

• Administer comprehensive vitamin supplementation including thiamine, vitamin B12, folic acid, pyridoxine, vitamin A, vitamin D, and zinc. 1
• B-complex vitamins are especially critical in alcohol users due to high prevalence of deficiency. 1
• Thiamine can be administered orally or enterally at 100-300 mg/day, though IV route is most efficient for acute deficiency (100-300 mg/day IV for 3-4 days). 1

Management of Alcohol Dependence

Pharmacologic Relapse Prevention

• In alcohol-dependent patients without advanced liver disease, consider naltrexone or acamprosate combined with counseling to reduce relapse risk. 1
• Naltrexone is a pure opioid antagonist that controls alcohol craving and lowers the risk of relapse. 3
• Acamprosate reduces withdrawal symptoms and alcohol craving, and is effective in maintaining abstinence when combined with counseling. 3
• Important caveat: Naltrexone can cause hepatocellular injury, so use with caution and monitor liver function. 3

Management of Complications

Gastrointestinal Bleeding

• For active bleeding related to alcoholic gastritis, endoscopic therapy is necessary. 1
• Angiographic embolization techniques should be considered when endoscopy is not effective. 1
• Perform urgent upper endoscopy to identify the bleeding source, as many patients have coexisting varices from underlying cirrhosis. 4

Nausea and Vomiting

• Use dopamine receptor antagonists (prochlorperazine, haloperidol, metoclopramide) for initial symptom control. 1
• For persistent symptoms, add 5-HT3 receptor antagonists or anticholinergic agents. 1
• Do not use metoclopramide as monotherapy for GERD-like symptoms in alcoholic gastritis, as it has fair evidence of being ineffective. 1

Critical Monitoring and Pitfalls

Nutritional Deficiencies

• Monitor closely for nutritional deficiencies, which are extremely common in alcoholic patients and significantly worsen outcomes. 1
• Chronic alcohol abuse causes atrophic gastritis with decreased hydrochloric acid secretion, which worsens with longer duration of alcohol use. 5

Alcohol Withdrawal

• Be vigilant for signs of alcohol withdrawal, which may require specific management protocols including benzodiazepines. 1

Helicobacter pylori Consideration

• Consider testing for Helicobacter pylori, as infection is common in alcoholics and contributes to gastritis through ammonia production from urea breakdown. 6
• Antibiotic eradication of H. pylori results in histological and symptomatic improvement in the majority of patients with alcoholic gastritis. 6

Coexisting Liver Disease

• Recognize that alcoholic gastritis often coexists with alcoholic liver disease, which may require additional management. 1
• If underlying cirrhosis is present, avoid nephrotoxic drugs and use diuretics sparingly to prevent acute kidney injury. 4

Pathophysiology Context

Understanding the mechanism helps guide therapy: Ethanol concentrations >20% rapidly destroy the gastric mucus-bicarbonate layer, increase mucosal permeability, cause surface cell exfoliation, deplete protective sulfhydryl compounds, and damage the mucosal microcirculation. 2 Ethanol also induces pyroptosis (inflammatory cell death) with caspase-1 activation and release of IL-1β and IL-18. 7 These mechanisms explain why abstinence and mucosal protection with PPIs are essential.